Fox Run Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Fox Run Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-13,300	Closed	-$165K	–	850
2016 Q4	$165K	Buy	+13,300	New	+$160K	0.09%	447
2016 Q3	–	Sell	-22,900	Closed	-$169K	–	817
2016 Q2	$169K	Buy	+22,900	New	+$172K	0.08%	466

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Fox Run Management's ARIA Position: Q1 2017 in Review

Fox Run Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 13,300 shares — an estimated $165K sold.

Fox Run Management first reported a position in ARIA in Q2 2016 and held it in 2 quarters. The position peaked at $169K in Q2 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Fox Run Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Fox Run Management sold 13,300 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $165K.
Fox Run Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2016 and held it in 2 quarters.
Fox Run Management's Ariad Pharmaceuticals Inc position peaked at $169K in Q2 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Fox Run Management's 13F filing for Q1 2017, filed 17 Apr 2017.